SCHEMBL15048504

SCHEMBL15048504

CCCCCCCCCCC(C)CCCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.57
ALDH1A1 P00352 2/20 0.57
HSD17B10 Q99714 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
TSHR P16473 1/20 0.57
ACE2 Q9BYF1 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.52
PRKD3 O94806 1/20 0.49
PRKCG P05129 1/20 0.49
PRKCB P05771 1/20 0.49
PRKCA P17252 1/20 0.49
PRKCH P24723 1/20 0.49
PRKCI P41743 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCZ Q05513 1/20 0.49
PRKCD Q05655 1/20 0.49
PRKD1 Q15139 1/20 0.49
SPHK1 Q9NYA1 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1658300 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6158737 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL27696843 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7797702 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15478674 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2223810 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2226904 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15478675 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL3369083 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2224957 0.98 ACE2 (0.55) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158620-A1 COMPOUND WITH BRANCHING ALKYL CHAINS, METHOD FOR PREPARING THE SAME, AND USE THEREOF IN PHOTOELECTRIC DEVICE BOE TECHNOLOGY GROUP CO LTD (CN) 2017-06-08 US disclosed
US-9209405-B2 Compound with branching alkyl chains, method for preparing the same, and use thereof in photoelectric device PEKING UNIVERSITY (CN) 2015-12-08 US disclosed
US-20140011973-A1 COMPOUND WITH BRANCHING ALKYL CHAINS, METHOD FOR PREPARING THE SAME, AND USE THEREOF IN PHOTOELECTRIC DEVICE PEKING UNIVERSITY (CN) 2014-01-09 US disclosed
US-8470565-B2 Use of ionic liquids for implementing a process for the preparation of biodiesel CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158620-A1 COMPOUND WITH BRANCHING ALKYL CHAINS, METHOD FOR PREPARING THE SAME, AND USE THEREOF IN PHOTOELECTRIC DEVICE PCNA, EPCAM, DNMT1 LMNA 336/4885ALDH1A1 1486/4885HSD17B10 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.